Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Octapharma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female age ≥18 years
Patient is scheduled to undego orthotopic liver transplantation (OLT)
Patient has a natural MAYO End-Stage Liver Disease (MELD) score of 15-40
Patient is willing to give voluntary written informed consent before any study- related procedure is to be performed that is not part of standard medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudicing future medical care
You may not be if
Patient has a history of severe hypersensitivity reaction to plasma-derived products or to any excipient of the investigational product
Patient is known to be IgA deficient with documented antibodies against IgA
Patient is a planned recipient for a living donor OLT
Patient has a severe deficiency of Protein S
Patient is currently participating in an interventional clinical study or has participated in one within 30 days of the date of their OLT
